Seasoned growth- and operations-focused investor with a background in scaling technology and services businesses across North America and Europe, often leading board-level strategy, M&A and capital formation. CLINE REASOR combines operating leadership with private equity and venture capital experience, advising portfolio companies on go-to-market, cost structure and governance. Relevant expertise includes commercial transformation, cross-border expansion and capital markets readiness; typically targets Series B–growth buyouts in SaaS, fintech and industrial services.
Seasoned growth- and operations-focused investor with a background in scaling technology and services businesses across North America and Europe, often leading board-level strategy, M&A and capital formation. CLINE REASOR combines operating leadership with private equity and venture capital experience, advising portfolio companies on go-to-market, cost structure and governance. Relevant expertise includes commercial transformation, cross-border expansion and capital markets readiness; typically targets Series B–growth buyouts in SaaS, fintech and industrial services.
Operator-led growth investor focused on scaling SaaS, fintech and industrial services businesses at Series B through growth buyout stages. Prefers lead or control positions that enable board-level influence and hands-on commercial transformation, cost-profile optimization and capital markets preparation. Investment decisions prioritize durable unit economics, repeatable go-to-market models and cross-border expansion capability. Typical horizon targets value-accretive exits via M&A or IPO within a multi-year growth cycle, deploying staged capital with disciplined performance milestones.
Operator-led growth investor focused on scaling SaaS, fintech and industrial services businesses at Series B through growth buyout stages. Prefers lead or control positions that enable board-level influence and hands-on commercial transformation, cost-profile optimization and capital markets preparation. Investment decisions prioritize durable unit economics, repeatable go-to-market models and cross-border expansion capability. Typical horizon targets value-accretive exits via M&A or IPO within a multi-year growth cycle, deploying staged capital with disciplined performance milestones.
| Trades 1202 | Longs Won 874/1202 72% | Profit Factor 26.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.33M |
| Average Win $257,407.17 | Best Trade (Oct 14) $25.6M | Sharpe Ratio -9.38 |
| Average Loss -$25,954.3 | Worst Trade (Oct 14) -$1.33M | Z-Score 4.91 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m 4d | Expectancy $180,083.91 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 30,303 | 27,273 | 24,242 | 21,212 | 18,182 | 15,152 | 12,121 | 9,091 | 6,061 | 3,030 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 33,849 | $6.55M | $11.66M | - | $5.11M | 78.02% | +0.697% |
ABBV AbbVie Inc. | 6,406 | $1.03M | $1.82M | - | $794,519.02 | 77.42% | +0.289% |
ABT Abbott Laboratories | 8,032 | $888,879.88 | $849,143.04 | - | -$39,736.84 | -4.47% | +0.994% |
ACN Accenture plc Class A | 2,151 | $754,807.45 | $484,305.61 | - | -$270,501.84 | -35.84% | +0.104% |
ADI Analog Devices, Inc. | 6,871 | $1.36M | $2.78M | - | $1.41M | 103.69% | +0.121% |
AFL Aflac Inc. | 9,690 | $800,647.08 | $1.15M | - | $352,366.02 | 44.01% | +0.796% |
AMP Ameriprise Financial, Inc. | 2,269 | $903,300.71 | $1.15M | - | $248,738.66 | 27.54% | +1.025% |
AMZN Amazon.com Inc | 12,955 | $2.09M | $3.29M | - | $1.2M | 57.19% | -0.451% |
ANET Arista Networks, Inc. | 12,742 | $1.45M | $2.31M | - | $861,299.05 | 59.33% | -2.182% |
AXP American Express Company | 3,902 | $843,402.7 | $1.24M | - | $397,043.1 | 47.08% | +1.284% |
AZN AstraZeneca PLC American Depositary Shares | 2,807 | $553,071.77 | $468,011.11 | - | -$85,060.66 | -15.38% | +0.03% |
AZO AutoZone Inc. | 85 | $219,777.1 | $266,607.17 | - | $46,830.07 | 21.31% | +2.515% |
BAC Bank of America Corporation | 43,746 | $1.82M | $2.28M | - | $458,595.32 | 25.15% | +0.899% |
BKNG Booking Holdings Inc. | 1,131 | $160,476.46 | $189,527.32 | - | $29,050.86 | 18.1% | +1.071% |
BP BP p.l.c. Sponsored ADR | 5,949 | $205,032.36 | $293,285.7 | - | $88,253.34 | 43.04% | +1.775% |
BRK-A Berkshire Hathaway Inc. | 1 | $798,442 | $798,254.39 | - | -$187.61 | -0.02% | +1.111% |
BRK-B Berkshire Hathaway Inc. | 9,134 | $3.31M | $4.86M | - | $1.55M | 46.93% | +1.244% |
BUD Anheuser-Busch InBev S.A. ADR | 3,733 | $268,274.96 | $309,727.01 | - | $41,452.05 | 15.45% | +2.079% |
BX Blackstone Inc. | 10,228 | $1.33M | $1.13M | - | -$201,921.66 | -15.19% | +0.907% |
C Citigroup Inc. | 2,988 | $338,873.88 | $376,129.44 | - | $37,255.56 | 10.99% | +2.167% |